TI ORDERPOINT Trademark

Trademark Overview


On Thursday, April 4, 2024, a trademark application was filed for TI ORDERPOINT with the United States Patent and Trademark Office. The USPTO has given the TI ORDERPOINT trademark a serial number of 98484454. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, October 25, 2024. This trademark is owned by QPharma, Inc.. The TI ORDERPOINT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the field of software as a service (SAAS)
ti orderpoint

General Information


Serial Number98484454
Word MarkTI ORDERPOINT
Filing DateThursday, April 4, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkTI ORDER POINT
Goods and ServicesConsulting services in the field of software as a service (SAAS)

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 4, 2024
Primary Code042
First Use Anywhere DateMonday, February 27, 2017
First Use In Commerce DateMonday, February 27, 2017

Trademark Owner History


Party NameQPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events


Event DateEvent Description
Thursday, April 4, 2024NEW APPLICATION ENTERED
Wednesday, September 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 25, 2024NON-FINAL ACTION WRITTEN
Friday, October 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 25, 2024NON-FINAL ACTION E-MAILED
Thursday, October 17, 2024ASSIGNED TO EXAMINER